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Background: Arginine Rich Motif (ARM) of HIV-1 Tat and Rev are extensively studied linear motifs (LMs). They are
already established as an inefficient bipartite nuclear localisation signal (NLS). The unusual passive diffusion of HIV-1
NLS tagged reporter proteins across the nucleus is due to an unknown competing functionality of ARM. Recent
findings about the role of retroviral proteins as a suppressor of RNA interference (RNAi) involving their basic
residues hint an interesting answer to this alternate functionality. The present work explores the role of HIV-1 ARM
as a uniquely evolved viral motif to combat Dicer dependent RNAi.
Results: We show that RNA binding ARM of both HIV-1 Tat and Rev is a LM with a pattern RXXRRXRRR unique to
viruses. Extending the in silico results to wet lab, we proved both HIV-1 Tat and Rev can suppress Dicer dependent
RNA silencing process involving ARM. We show, HIV-1 Tat and Rev and their corresponding ARM can bind the RISC
loading complex (RLC) components TRBP and PACT confirming ARM as an independent RNAi suppression motif.
Enhancement of RNAi in infection scenario through enoxacin increases HIV-1 replication as indicated by p24 levels.
Except Dicer, all other cytoplasmic RNAi components enhance HIV-1 replication, indicating crucial role of Dicer
independent (Ago2 dependent) RNAi pathway in HIV-1 infection. Sequence and structural analysis of endo/exo-
microRNA precursors known to be regulated in HIV-1 infection highlights differential features of microRNA
biogenesis. One such set of miRNA is viral TAR encoded HIV-1-miR-TAR-5p (Tar1) and HIV-1-miR-TAR-3p (Tar2) that
are known to be present throughout the HIV-1 life cycle. Our qPCR results showed that enoxacin increases Tar2
miRNA level which is interesting as Tar2 precursor shows Ago2 dependent processing features.
Conclusions: We establish HIV-1 ARM as a novel viral motif evolved to target the Dicer dependent RNAi pathway.
The conservation of such motif in other viral proteins possibly explains the potent suppression of Dicer dependent
RNAi. Our model argues that HIV-1 suppress the processing of siRNAs through inhibition of Dicer while at the same
time manipulates the RNAi machinery to process miRNA involved in HIV-1 replication from Dicer independent
pathways.Background
Short Linear Motifs (also known as SLiMs, Linear Motifs
or mini motifs) are short stretches of protein sequence
which mediate protein-protein interaction [1]. At the
molecular level, linear motifs (LMs) are modular units
that are separate from other functional properties of
protein molecule. They are typically short linear peptides
of around 3-12 amino acids with a particular sequence
pattern where few amino acid are fixed while others* Correspondence: sanket@nii.res.in
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reproduction in any medium, provided the orallow variations [2]. In general, LM imparts specific recog-
nition and targeting activities (via domain-motif interac-
tions) to molecule in which they occur [3]. In a cellular
context, LMs are involved in protein-protein interactions,
protein trafficking, and posttranslational modifications [4].
The short generation time and high mutation rate of RNA
genome in association with natural selection has led to
evolution of SLiMs that rewire cellular machinery [5,6].
Poor conservation over long evolutionary distances and
plasticity of LMs make them a widely used functional
module in pathogenic viruses such as Human Immuno-
deficiency Virus type 1 (HIV-1) [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identified as independent protein modules. For example,
arginine rich motif (ARM) (residue 48-60 in Tat and
residue 34–50 in Rev) is one such prototype of protein
modules that are functionally active as cell-penetrating
peptides (CPP) [7]. It was observed that inverse and
retro forms of HIV-1 ARM are fully functional and
ARM mediated delivery of cargo inside the cell is
dependent on its size [8]. ARM of Tat and Rev in its
physiological context binds cis-acting RNA elements like
Transactivation Responsive RNA (TAR) and Rev Re-
sponsive Element (RRE) of viral genome respectively.
Conventionally, the viral ARM mediates specific RNA
recognition and is also considered as non-classical
bipartite variant of the positively charged nuclear
localization signal (NLS). HIV-1 ARM binds both
importin α and importin β in vitro [9], although ARM
mediated nuclear export is silenced in vivo [10]. The
inefficient transport property of HIV-1 NLS is due to the
existence of two competing functionalities within the
same basic sequence stretch of viral ARM [11,12]. Inter-
estingly, these importin binding properties of viral ARM
(RKKRRQRRR) can be differentially altered by substitut-
ing the last three arginine residues of the ARM to gly-
cine residues (RKKRRQGGG). Such mutation restores
the importin α binding preferentially over importin β as
is the case of effective NLS (SV40 NLS) [9,11,12]. Some
reports also suggest the overwhelming binding affinity
of the ARM towards negatively charged biomolecules
(e.g. RNAs) as a reason for effective inhibition of the im-
port complex in vivo [10] while others suspected cytoplas-
mic proteins as a competitor of the import carriers [13].
Presence of three additional terminal arginine residues in
an otherwise effective NLS, raises many questions includ-
ing what is the alternate cytoplasmic functionality of ar-
ginine rich variant of NLS, why a strong NLS has been
attenuated into bi-functional LM in HIV-1 and how a
weak NLS provides replication benefit to virus?
RNA Interference (RNAi) or gene silencing is an im-
portant cellular pathway that regulates eukaryotic gene
expression and is also involved in innate immune re-
sponse against viral infections [14]. Recently, several
viral mechanisms for escaping antiviral RNAi has been
discovered which includes suppression of RNAi, muta-
tional escape from RNAi and modulation of the cell’s
microRNA (miRNA) profile [15]. Similar to plant and
insect viruses, several mammalian viruses encoding
RNAi silencing suppression (RSS) function were re-
ported [16]. These RNAi suppressors are multifunctional
proteins that were previously shown to block innate
antiviral immune responses involving the interferon
(IFN) pathway [14]. Characteristics like early phase
expression, non-structural nature and the cytoplasmic
localization property of viral proteins has been cited forpotent RNAi suppression [17]. Many concerns have been
raised regarding the specificity and physiological rele-
vance of putative RNAi suppressor as all of these pro-
teins also have other well-defined and essential functions
[18]. It has been suggested that the first step to deter-
mine the precise role of RSS activity in the viral life cycle
is to identify the specific functional module associated
with RNAi suppression in viral polypeptides [17]. Al-
though analysis of SLiM from animal viruses which in-
hibits RNAi is yet to be reported, but it has been shown
that heterologous suppressor proteins that inactivates
RNAi-mediated host defences shows dsRNA binding
functionality [19]. A classic example of RSS associated
LM has been reported in plant viral proteins containing
GW/WG motifs that play a critical role in disabling
RNA-induced silencing complex (RISC) by sequestering
Ago protein [20,21].
HIV-1 uses two different strategies to avoid RNAi me-
diated inhibition which are induced and intrinsic [22,23].
Induced RNAi resistance involves the selection of muta-
tions in the target sequence or mutations outside the
target sequence (point mutations, deletion) that induce a
new RNA structure blocking the RNAi inhibition. Intrin-
sic RNAi resistance utilizes Tat to abrogate the ability of
Dicer that results in inhibition of siRNA maturation
[24-26]. Interestingly HIV-1 Rev homologue, HTLV-1
Rex has also been shown to interact with Dicer, sup-
pressing RNAi silencing [27]. Strikingly, in both the
studies, the retroviral proteins’ (Tat and Rex) arginine
rich region was involved in interaction with Dicer.
Hence a detailed analysis of RNA binding viral ARM
offers a testable hypothesis which can correlate Dicer
dependent RNAi suppression with the unknown cyto-
plasmic functionality of HIV-1 ARM. However, it is still
important to know the physiological relevance of RSS
activity for a virus such as HIV-1 which is known to
modulate microRNAs pathway for a successful replica-
tion [28]. So far there is a poor evidence of global RNAi
suppression in HIV-1 infection, which conflicts with
predicted RSS activity of its suppressor ARM. In fact,
endogenous microRNAs pathway is still operative that
could process both viral and cellular precursor miRNA
to enhance HIV-1 replication [29,30]. So an explaination
is needed for the biogenesis of microRNAs in case of
HIV-1 infection that blocks the key central enzyme
Dicer through Tat [24] and also downregulates Dicer
expression in macrophages through Vpr [31]. Inhibition
of Dicer both at RNA and protein level is a general trend
by many mammalian viruses [32,33]. Recently, Ago2 de-
pendent dicing activity has been discovered establishing
Dicer independent RNAi biogenesis [34,35]. This non-
canonical pathway plays a role in the production of non-
coding RNA such as piRNA for transposon regulation
[36] and miRNA for regulating gene expression [37].
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modulation of cytoplasmic RNAi to selectively favor the
demands of HIV-1 is unknown.
In the present work, we have established the identity
of HIV-1 ARM as a unique viral motif which targets the
RNAi silencing pathway. Using bioinformatics we define
the RNA binding region (ARM) of HIV-1 Tat and Rev as
a SLiM unique to viruses. Interactome network maps of
HIV-1 Tat and Rev were analysed to deduce the com-
mon interacting partners that can be uniquely attributed
to the viral ARM. Using the computational approach we
predicted that ARM could possibly target RNAi path-
way. We produced experimental evidences for the RSS
activity of ARMs in HIV-1 proteins. Using transient ex-
pression assays that use Dicer dependent RNA silencing
of reporter gene followed by reversal of silencing by sup-
pressor proteins, we identified the RSS activity of HIV-1
Rev that works in additive fashion with HIV-1 Tat. We
also demonstrate the role of ARM in the suppression ac-
tivity of these HIV-1 proteins in the reversal-of-RNAi-
silencing assay. Furthermore, we confirm the independent
nature of ARM as a LM sufficient to confer gain of RSS
functionality to reporter proteins. We go on finding the
mechanistic detail of this RNAi suppression motif by
investigating its critical role in targeting of RLC compo-
nents by HIV-1 regulatory proteins. We also prove that
HIV-1 ARM can bind RNAi components autonomously
confirming its modular nature. To resolve the discrepan-
cies reported in current literature, we have analyzed the
effect of RNAi and its components on HIV-1 replication
using indicative p24 levels. Our results suggest that
RNAi in its physiological niche of HIV-1 infection and
all its key cytoplasmic components except Dicer, posi-
tively modulate HIV-1 replication.
Results
ARM of Tat and Rev carries a SLiM with a pattern
RXXRRXRRR unique to viruses
Linear motifs (LMs) are 3-12 amino acid long peptides
of conserved sequence and flexible structure. This defin-
ition was applied to a consensus of 170 protein se-
quences each of HIV-1 Tat and Rev from subtype
references of 2010 HIV sequence compendia. Shannon
entropy plots (Figure 1A) of both HIV-1 Tat and Rev
multiple sequence alignment (MSA) reveal relative con-
servation of motif pattern RXXRRXRRR at N-terminus
region. The ARM of HIV-1 Tat is in residue position
48–60 while that of HIV-1 Rev is in position 35–50. To
validate arginine rich sequence as a LM, we analyzed
flexibility of motif pattern and its embedding structural
context using disorder profile. The IUpred score that
shows the high flexibility index with a cut off of 0.5
shows the motif to be present in disordered region
of both the Tat and Rev proteins (Figure 1B). Theconservation of ARM with pattern RXXRRXRRR in
other viral proteins (Figure 1C) further indicate that
ARM can act as a viral motif. To check the molecular
mimicry of viral ARM with host motifs we compared
the distribution of basic amino acids in two linear
motif patterns in the host proteome (Figure 1D). One
is AXXAAX that is a well defined classical nuclear
localization signal (NLS) pattern of host while
AXXAAXAAA is an uncharacterized viral LM. A can be
any of the three basic amino acids and X any amino acid.
RXXRRXRRR shows zero instances in human proteome
confirming the evolution of ARM exclusive to the viruses.
ARM could target proteins involved in nucleic acid based
immunity
To deduce the physiological function of ARM, molecular
interaction network for Tat and Rev was constructed
using HIV-1 interaction database. The interacting part-
ners for both HIV-1 Tat and Rev are shown in Figure 2A.
As proteins with identical motif show similar inter-
actome profiles, we assessed functional classification of
25 common interacting partners of Tat and Rev. The
best represented molecular and biological function in-
volved RNA binding and mRNA metabolic process that
can be attributed to the presence of ARM. Most SLiMs
provides gain of interaction function through domain-
motif interaction. To find the ARM targeted protein
domains, we carried out domain profile analysis of com-
monly targeted proteins from Figure 2A. The common
interacting proteins are decomposed into their functional
units (domains) and clustered according to their known
domain-domain interactions (Figure 2B and Figure 2C).
The domain profiles (Figure 2D) of common interacting
partners and RNA Interference (RNAi) proteins (Drosha,
DGCR8, XPO5, RAN, DICER1, DHX9, TRBP, PACT,
Ago2) highlighted that both dataset are enriched for
DSRM and P-loop_NTPase (AAA) domain superfamily.
Using these protein domains as functional units, we ex-
plored possible domain clubs (proteins) that are probable
interacting partners of ARM. Figure 2E shows the pre-
dicted host proteins that could interact with ARM are
involved in nucleic acid based immunity including RNAi.
Viral proteins can suppress Dicer dependent RNA
silencing process using ARM
ARM deletion mutants of HIV-1 Tat and Rev were
cloned with Myc tag and their expression was checked
(Figure 3A). Figure 3B shows that there is no significant
change in the stability of Myc tagged Tat and Rev and
their respective deletion mutants. To investigate the role
of ARM in the RSS function, Tat, Rev and their respective
deletion mutants were used in the reversal-of-Dicer-
dependent-silencing assay based on GFP reporter. Figure 3C
shows that both Tat and Rev can act as RSS by reverting
Figure 1 (See legend on next page.)
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Figure 1 Linear Motif discovery based on motif definition. To discover linear motif (LM), multiple sequence alignment (MSA), Shannon
entropy plots and sequence context in terms of structural disorder were used. (A) shows the Shannon entropy plot of HIV-1 Tat and Rev to
analyze variation in sequence conservation. This plot quantifies diversity using MSA at each single amino acid position in full length protein.
Amino acid positions that do not exhibit any changes in protein sequences have entropy of zero whereas a position that shows highly variable
substitution is represented by large peaks. The basic region of both Tat and Rev with a motif pattern RXXRRXRRR is present in regions that show
more than 90% conservation indicating their importance in viral genome. Disorder predictions using IUPred plot (B) indicates that Arginine Rich
Motif (ARM) in both Tat and Rev is above the threshold of 0.5 predicting their nature as natively disordered polypeptide. (C) shows the sequence
comparison of the ARM in different viral proteins of Human immunodeficiency virus type 1 (HIV-1), Human T-lymphotropic virus (HTLV1), Human
herpes virus (HHV) and adenovirus (Ad). Tat, Rev, Rex, UL56, UL54, pVII, E4orf4 are viral open reading frames and their corresponding ARM are
shown with arginine residues highlighted in red. The numbers identify residue positions in full length proteins. (D) shows the distribution of basic
amino acids in two LM patterns in the host proteome. One is AXXAAX that is a well defined classical NLS pattern of host while AXXAAXAAA is an
uncharacterized viral LM. This analysis highlights the specificity of ARM from viral proteins as a Short linear motif (SLiM).
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copy images (Figure 3D) while deletion of ARM
compromised RSS activity. The same results were con-
firmed by flow cytometry (Figure 3E). The RSS effect of
HIV-1 Tat and Rev was additive in nature. In addition
NS4B, a Dengue viral protein that has a similar ARM as
that of HIV-1, shows RSS activity. Deletion of ARM in
NS4B compromises the RSS function (Additional file 1:
Figure S1).
HIV-1 ARM independently confers Dicer dependent RNAi
suppressor function
In order to show that ARM independently confers RNAi
suppressor function it was fused to a reporter protein
RFP (ARM RFP). Figure 4A shows that ARM is sufficient
to provide more than 2 fold suppressor activity to ARM
RFP as compared to control hence proving that HIV-1
ARM can independently confer RNAi suppressor func-
tion. Figure 4B shows quantification of 4A. To investi-
gate the role of methylation in ARM mediated RNAi
suppression, Adox (a general methylation inhibitor) was
used in the reversal-of-Dicer-dependent-silencing assay
based on GFP reporter. Results (Figure 4C) show that
ARM mediated RNAi suppressor function is independ-
ent of arginine methylation. Figure 4D shows the quan-
tification of flow cytometry in 4C. The same results
were confirmed using Dicer-dependent-silencing assay
based on luciferase reporter (Figure 4E).
HIV-1 Tat, Rev and ARM can bind TRBP and PACT
As suggested by our in silico results (Figure 2), the prob-
able mechanism of ARM to act as Dicer dependent
RNAi suppressor is possibly through interaction with
proteins which are enriched in Double-stranded RNA
binding motif (DSRM) and/or P-loop_NTPase domains.
To examine this possibility, we evaluated the ability
of HIV-1 Tat and Rev, their respective ARM deletion
mutants and ARM containing reporter protein to bind
components of RISC loading complex (TRBP and PACT
as both constitutes DSRM in their structure). As shownin co-immunoprecipitation results (Figure 5A and
Figure 5B), both wild type Tat and Rev are able to bind
TRBP and PACT whereas their respective ARM deletion
mutants shows differential binding ability. Tat ARM
mutant was fully functional in binding both TRBP and
PACT while Rev ARM mutant showed compromised
TRBP and PACT binding. The binding of Tat and Rev
also remains intact even in the presence of methylation
inhibitor (Adox) suggesting RNAi suppression is inde-
pendent of the methylation status of suppressor proteins
(Figure 5A and Figure 5B). Figure 5C and 5D shows the
relative quantification plot for 5A and 5B respectively.
To confirm ARM as an RNAi suppression motif we also
showed its ability to independently confer gain of TRBP
and PACT binding functionality to reporter GST pro-
tein. As shown in Figure 5E, both Tat and Rev ARM
fused GST (TmGST and RmGST respectively) can bind
TRBP and PACT whereas GST alone fails to do so. To
address whether such protein interactions require RNA
as a mediator, the cell extracts were treated with RNase-
A prior to co-immunoprecipitation. Figure 5F shows
that wild type Rev is able to bind TRBP and PACT even
in the absence of RNA. RmGST also shows similar
results with TRBP and PACT. RNAse-A treatment sub-
stantially increases this binding probably because of the
competitive RNA binding by ARM containing proteins.
As this competition is diminished by RNAse-A treat-
ment, more ARM could be rapidly available for inter-
action with host proteins.
RNAi affects HIV-1 replication
To establish the role of cellular RNAi in HIV-1 infection,
latently infected T-cells (J1.1) were treated with enoxacin
(TRBP dependent RNAi enhancing drug) [38,39]. The
drug treatment at 50 μM for 48 hours reactivates latent
HIV-1 which is comparable to TNF-α (10 ng/ml, a
known activator of HIV-1 latency) as shown by p24
western blots (Figure 6A). This suggests a positive
co-relation of RNAi and HIV-1. To check the effect of
cytoplasmic components of RNAi on HIV-1 replication,
Figure 2 (See legend on next page.)
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Figure 2 Bioinformatics based functional assessment of HIV-1 ARM. To assess the functional role of viral ARM, molecular interaction
networks for HIV-1 Tat and Rev proteins was constructed using HIV-1 interaction database (A). The Tat targeted host proteins are in green colour,
Rev targeted in red and common interacting partners in purple. Individual proteins are depicted as nodes and edges represent interactions. The
functional assignment of the commonly targeted proteins are according to gene annotation (GO) (molecular function and biological process)
and is summarised with top 8 GO term with p value <10-7 along with their cluster frequency as percentage. (B) shows domain profiling of
commonly targeted host proteins by ARM is based on correlated domain structures. In the matrix representation, both rows and columns are
domains of targeted proteins, “1” and “0” represent the presence or absence of homo or heterotypic domain interaction among them
respectively. Single linkage hierarchial clustering (C) based on Euclidean distance gives clusters of domains (domain clubs) as a possible protein
context that can be targeted by ARM containing proteins. The red box indicates domain clubs shared by pathways of nucleic acid based on
immunity. (D) shows the most represented structural domains in commonly targeted host proteins and RNAi pathway. In both the pie chart,
Double-stranded RNA binding motif (DSRM) and P-loop_NTPase (AAA domain) are common and enriched. Based on these domains and the club
to which they belong, most probable targets of viral ARM are shown in (E). Refer method for details.
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DNAzyme mediated knockdowns of cytoplasmic RNAi
components. Co-transfection of pNL4.3 (HIV-1 molecu-
lar infectious clone) along with PACT, TRBP, RHA,
Dicer and Ago2 with respective DNAzyme (for sequence
specific knockdowns, Figure 6B) was carried out and p24
levels were analyzed using western blotting. Figure 6C
shows that except Dicer, other cytoplasmic RNAi compo-
nents promote HIV-1 replication. The effect was specific-
ally reversed by DNAzyme mediated knockdown.MicroRNA profile in HIV-1 infection suggests differential
role of Dicer dependent and independent RNAi
To analyze the Dicer dependent and Dicer independent
RNAi in HIV-1 infection, we assessed Dicer and Ago2
processed microRNA signature pattern in precursor
microRNA (using miRNAMap, a structural database of
miRNAs) that are known to be differentially regulated in
HIV-1 infection. Sequence/structure pattern in microRNA
terminal loop shows distinct molecular features suggesting
different pathway of microRNA biogenesis in HIV-1 repli-
cation. Figure 7A shows Dicer dependent features in hsa-
miR-23a, 27a, 29a, 29b and 379 (that are known to be
inhibited in HIV-1) while Ago2 dependent molecular fea-
tures of miRNA biogenesis was evident in hsa-miR-32,
34a, 181b-1, 203 and 449 (that are known to be up regu-
lated in HIV-1 infection). To check whether exogenous
viral microRNA can adapt to differential microRNA bio-
genesis in HIV-1 infected cells, sequence and structural
features of TAR precursor microRNA was analyzed.
Figure 7B shows that TAR microRNA precursor carries
Ago2 processed features that predict the maturation of
only HIV-TAR-3p (TAR2). A quantitative PCR of TAR1
(miR-TAR-5p from 5’ arm) and TAR2 (miR-TAR-3p from
3’ arm) processed mature miRNA was also done in infec-
tion based scenario (Jurkat cells) and in enoxacin treated
latently infected J1.1 T cells. qPCR in VSV-G pseudotyped
HIV-1 infected T-cells shows expression of TAR2 is pre-
dominant over TAR1 (Figure 7C). Similar result were
found when latently infected T cells were activated byenoxacin treatment while a negative control (hsa-miR16)
shows no change (Figure 7, panel D-F).
Discussion
RNA interference (RNAi) is a natural process whereby
double-stranded RNA (dsRNA) induces sequence-specific
degradation of RNA. It is the predominant mechanism
of antiviral defence in plants and invertebrates but in
mammals RNAi chiefly regulates host cellular processes
through miRNA pathway and restricts transposable ele-
ments [15]. In vertebrate cells, there has been evolutionary
progression from RNA-based immunity to protein-based
immunity [40,41]. This is also evident from the phylogen-
etic analysis and evolutionary conservation of RNAi com-
ponents. For example, plants reveal multiple homologues
of dsRNA-binding Dicer while mammals show only one
[42]. The reason of such drastic shift from RNA to protein
based innate immunity in vertebrates is not clear. We
hypothesized that HIV-1 (along with other Retroviruses)
might enocde an unidentified Dicer dependent RNAi sup-
pressor function that counteracts antiviral RNAi and host
strikes back by negatively selecting antiviral RNAi.
Plant viruses are known to exploit short linear motifs
(SLiMs) by acquiring GW/WG peptides in viral ORFs
which binds to Ago proteins making them incompetent
in targeting viral RNA. However, no such generalized
linear motif (LM) is reported in case of any mammalian
virus that can be associated with the modulation of
RNAi surveillance. In the present work, we started with
bioinformatics analysis that predicts HIV-1 Arginine
Rich Motif (ARM) as a unique viral motif that targets
the nucleic acid based immunity including RNAi path-
way. Using Dicer dependent RNAi silencing suppressor
(RSS) assay the suppression activity of HIV-1 Tat and
Rev, their corresponding ARM deletion mutants and
ARM fused reporter proteins were measured. HIV-1 Tat
and Rev both can suppress Dicer dependent RNAi silen-
cing process while the ARM deleted mutants show
compromised RSS activity clearly indicating the import-
ance of ARM. Furthermore, we have shown that the
HIV-1 ARM alone was sufficient to suppress RNAi and
Figure 3 (See legend on next page.)
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Figure 3 HIV-1 Tat and Rev can suppress Dicer dependent RNAi process involving ARM. HEK 293 T cells were transfected with an
expression plasmid for HIV-1 Tat, Rev and their corresponding ARM deletion mutants i.e. ΔTat and Δ Rev (1 μg each). In ARM mutants the ARM
region was deleted (48-60 in Tat and 35-50 in Rev). (A) shows the expression levels of wild type and ARM mutants of Tat and Rev respectively.
The stability of Tat, Rev and their corresponding ARM deletion mutants was determined using Cycloheximide chase for 8 hours (B). HEK 293 T
cells were co-transfected with expression plasmid for GFP, Dicer dependent shRNA against GFP (0.5 μg) along with Tat, Rev and their
corresponding ARM deletion mutants. GFP expression was measured at 48 hours post transfection. (C) shows fluorescence microscopic images of
RNAi suppression by HIV-1 Tat, Rev and their ARM deletion mutants. (D) is a Flow cytometric analysis to show the suppressor effect of HIV-1 Tat,
Rev and ARM deletion mutants on GFP expression in Dicer dependent RNAi suppressor assay. Dot plot depicts the number of cells (counts) on
Y-axis versus the expression of GFP reporter (FL1) on X-axis. (E) is a histogram plot of suppressor assay. The p values indicate that the difference
between the wild type Tat/Rev and corresponding ARM mutant is significant.
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status. We investigated the critical role of ARM in
targeting components of RISC Loading Complex (RLC).
Both HIV-1 Tat,Rev were able to bind TRBP/PACT and
the binding was not abolished in the presence of general
methylation inhibitor (Adox) [43]). Adox appears to in-
crease this binding which could be due to the absence of
methylation on arginine residues that are now easily
available to interact more strongly with TRBP/PACT.
However, deletion of ARM alters the RLC binding. ARM
deletion mutant of Tat showed increased relative binding
which can be explained on the basis of its structure
which is unusually sticky in nature. While ARM delta
Rev failed to bind TRBP/PACT as expected. We further
assessed the functionality of viral ARM using novel
chimeric proteins. In the co-immunoprecipitation, we
found that ARM confers a gain of interaction function
to the reporter protein. Hence, we prove that HIV-1
ARM can bind RNAi components independently con-
firming its modular nature.
To understand the role of cytoplasmic RNAi in the
HIV-1 replication, we used RNAi enhancing drug (enoxacin)
in HIV-1 latently infected T cells. Enoxacin is shown to
enhance RNAi processing of RISC specifically through
TRBP [38]. Our results showed that enoxacin treatment
reactivates latently HIV-1 infected T cells which is com-
parable to a known latency reactivator i.e., TNF-α. To gain
an insight in the mechanism of enoxacin dependent in-
crease in p24 levels of latently infected T-cells, we ana-
lyzed the effects of RNAi components on HIV-1
replication. Except Dicer, all other cytoplasmic RNAi com-
ponents (RHA, PACT, TRBP and Ago2) were shown to
positively modulate HIV-1 replication as indicated by p24
western blots. Our studies show the role of HIV-1 ARM
as a general suppressor of Dicer dependent RNAi. But at
the same time we observe a positive correlation between
RNAi and HIV-1 replication as measured by p24 western
blotting after enoxacin treatment. This apparent paradox
is resolved by careful assessment of the microRNA bio-
genesis in the HIV-1 infection. The RLC comprises of 4
protein components: Dicer, PACT, TRBP and RHA. The
RLC is involved in the activation of RNA induced silen-
cing complex (RISC) which uses siRNA to degrade theviral genome that is known as Dicer dependent RNAi.
RISC is also involved in the processing of miRNA from
precursor miRNA. These miRNAs are known to be differ-
entially expressed (at the transcription level) in HIV-1
infection. Recently, Dicer independent activation of RISC
and miRNA processing has been shown [35]. To under-
stand the role of Dicer dependent and independent path-
ways in HIV-1 replication, we analysed the differentially
regulated miRNAs in HIV-1 infection [29,44-47] and their
corresponding sequence/structure signatures that deter-
mines their biogenesis. Interestingly, the down-regulated
microRNAs hsa-miR-23a, 27a, 29a, 29b and 379 and up-
regulated microRNAs hsa-miR-32, 34a, 181b-1, 203 and
449 show different features in terminal loop. The terminal
loop plays a very critical role in Dicer and Ago2 substrate
specificity for microRNA biogenesis [48-50]. Down-
regulated microRNAs show a large terminal loop that
enhances pre-miRNA cleavage by Dicer. The up-regulated
miRNAs shows a tight, short loop feature which is essen-
tial for Ago2 cleavage. As HIV-1 TAR2 also shows a simi-
lar loop feature, we predicted it to be processed by Ago2
in case of Dicer inhibition and show preferential release as
already reported in literature [51]. Our qPCR results in
infectious scenario confirmed these predictions. Similar
results were seen when TRBP dependent RNAi was en-
hanced using enoxacin in latently infected T-cells. The
presented data suggest a possible role of Dicer independ-
ent (Ago2 based) RNAi in HIV-1 infection. Ago2 is
known to be associated with many more miRNAs in-
cluding miR-30a, 21, 92a, 99b, 183, 27a, 151a, 30d, 182,
25 [52] that might influence HIV-1 replication. Also
Ago2 is known to be essential for HIV-1 replication
[53]. As interferon response and RNAi silencing in
HIV-1 infection involves downregulation of Dicer [32]
and possible upregulation of many Dicer independent
microRNAs [54], further research on Ago2 processed en-
dogenous and exo-miRNAs might explain the cross talks
these two antiviral pathway play in modulating the HIV-
1 replication. We hypothesize that Ago2 dependent
miRNAs could also play a role in innate and adaptive
immunity explaining why the evolutionary ‘fossils’ of
RNAi components are still conserved in vertebrates for
robust viral restriction.
Figure 4 (See legend on next page.)
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Figure 4 HIV-1 ARM independently confers Dicer dependent RNAi suppressor function. ARM was fused to a reporter protein RFP (ARM RFP).
HEK 293 T cells were co-transfected with an expression plasmid for GFP and Dicer dependent shRNA against GFP (0.5 μg) along with RFP vector/ARM
RFP. (A) shows a histogram plot (Events on Y axis and expression of GFP (FL1) on X axis) of suppressor assay (as described in 3D) where RSS activity is
independently conferred by fusion of ARM to the reporter protein (RFP). The bar graph in (B) shows the quantification of the histogram. (C) shows
flow cytometric analysis (Histogram plot showing number of cells (counts) on Y-axis versus the expression of GFP reporter (FL1) on X-axis) and
corresponding fluorescence microscopy images of the suppressor assay of ARM-Reporter in the presence and absence of 30 μM Adox (Adenosine,
periodate). The bar graph in (D) shows the quantification of the histogram. (E) show the ARM mediated reversal of Dicer-dependent-silencing assay
based on luciferase reporter with a significant p value (< 0.001).
Ponia et al. Retrovirology 2013, 10:97 Page 11 of 17
http://www.retrovirology.com/content/10/1/97Conclusions
Our work explains that Dicer dependent RNAi restric-
tion is suppressed in case of successful HIV-1 replica-
tion. We have established the case of HIV-1 ARM as an
example of a viral module that can effectively manipu-
late the host restriction pathway. The presence of simi-
lar arginine rich linear motifs in other viral proteins
(Additional file 1: Figure S1) suggests a general modus
operandi for RNAi modulation. Now it is possible to
explain the potent suppression of Dicer dependent
RNAi pathway in other viruses based on the presence or
absence of such ARM in their respective proteome.
Methods
Evolutionary conservation, disorder prediction & motif
search
Sequence conservation analysis was based on multiple
sequence alignment of HIV-1 Tat and Rev Protein se-
quences from Los Alamos HIV sequence database, HIV
premade alignments (http://www.hiv.lanl.gov/content/
sequence/HIV/mainpage.html). Shannon entropy plots
were made using Shannon Entropy-One tool (http://
www.hiv.lanl.gov/content/sequence/ENTROPY/entropy_
one.html). The flexible structural context was analysed
using disorder profile generated via IUPred (http://
iupred.enzim.hu/). Protein BLAST search (blastP) was
used for evaluating arginine rich motif (ARM) conserva-
tion in other viral protein (Viruses, taxid: 10239).
SLiMSearch (http://bioware.ucd.ie/~compass/biowareweb/)
was used to search the ARM in the context of human
proteome. SLiMSearch was used to identify occurrences
of these two defined motif patterns against human prote-
ome using evolutionary conservation and structural dis-
order context statistics. Only those instances are counted
that are above the cut off threshold (p = 0.001, IUP = 0.5).
See these websites for details of bioinformatics analysis.
Interactome generation and functional classification
The 246 unique interacting partners for HIV-1 Tat
interactome has been taken from two sources. One is
BioGRID (http://thebiogrid.org/) and the other from
reference [55]. The 240 unique interacting partners for
HIV-1 Rev are entirely taken from reference [56]. The
molecular interaction network diagrams were generatedby Cytoscape [57] using import network from table
option. To make the interaction maps more informative,
previously established host interactions were also inte-
grated employing publicly available Protein-Protein
Interaction database HPRD (http://www.hprd.org/). To
examine molecular functions and biological processes of
common host targets of HIV-1 Tat and Rev, a systematic
gene annotation using BiNGO [58] was carried out on
25 host protein in cytoscape.
Domain composition, domain profiling and protein target
prediction based on domain clubs
To document the conserved structural domain profiles
on 25 commonly targeted host proteins, we utilised
batch search tool of conserved domain database (CDD).
For every domain annotation, we counted the number of
protein instances in the interactome dataset. All the top
scorers in percentage were considered to be the most
represented protein domains in the common inter-
actome of HIV-1 Tat and Rev. The conserved structural
domain profiles of common targets were than subjected
to a domain-domain matrix to map the homo or hetero-
typic domain interaction among them using domine
database (http://domine.utdallas.edu/cgi-bin/Domine). In
the matrix representation “1” and “0” represent the pres-
ence or absence of interaction respectively. The domain
interaction profiles were then clustered using single link-
age hierarchical clustering based on Euclidean distances.
The domain clusters were then used to predict the pro-
teins as the possible target of ARM using domain club
search. (http://pawsonlab.mshri.on.ca/DomainClub/domain
Club.php).
Plasmids, cell culture and transfection
RetroQ-ZsGreen vector (Clontech) co-expressing GFP
under CMV promoter and Dicer processed shRNA
against GFP under U6 promoter was used as reported in
reference [14]. The HIV-1 Tat, Rev and their respective
mutants (Delta ARM mutants, 48-60 in Tat and 35-50 in
Rev) were cloned downstream of the CMV promoter in
the pCDNA vector. They were also subcloned in Myc-
Tag Vector from Clontech. Rev ARM motif was cloned
as fusion with RFP using DsRed-Express Fluorescent






Figure 5 (See legend on next page.)
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Figure 5 HIV-1 ARM confers interaction ability with components of RISC Loading Complex (RLC). HEK 293 T cells were co-transfected with
His TRBP, His PACT and Myc Tat, Myc Rev, and their corresponding ARM deletion mutants in the presence and absence of Adox. 48 hours later
cell lysates were subjected to co-immunoprecipitation as described in methods. TRBP and PACT immunoprecipitates were assessed by western
blotting using anti-His and co-immunoprecipitated Tat, Rev and their ARM deletion mutants were detected using anti-myc (A and B). (C) and (D)
show the relative binding of ARM deleted mutants with respect to wild type proteins with TRBP and PACT respectively. (E) shows co-immunoprecipitation
of His-TRBP and HA-PACT with GST and GST fused HIV-1 ARM (TmGST and RmGST) using a similar protocol as in 5A (using Ni–NTA in first case and
Glutathione Beads in second). (F) is co-immunoprecipitation analysis of His TRBP and His PACT with Myc Rev and RmGST in the presence and absence
of 50 μg/ml of RNase A.
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TRBP and PACT were cloned as a fusion with His tag
using pCDNA vector and as HA-tagged using HA vector
from Clontech. Dicer was cloned as a fusion with Myc
tag using Myc vector from Clontech. pcDNA3-HA RHAA B
C
Figure 6 RNAi affects HIV-1 replication. Latently infected T cells (J1.1) w
(A) shows p24 levels by western blot on enoxacin and TNF-α treatment. (B
RLC components PACT, TRBP, Dicer and Ago2. (C) shows the levels of p24
Overexpression and both. GAPDH was used as a loading control.construct was a kind gift from Dr. Toshihiro Nakajima
(St. Mariana University school of Medicine, Japan). HA-
Ago2 was procured from Addgene. The 10-23 DNAzyme
sequence for knock down of TRBP, PACT, RHA, Ago2
and Dicer is provided in Additional file 2: Table S1. HEKere treated with TNF-α (10 ng/ml) and enoxacin (50 μM) for 48 hours.
) shows use of 10-23 DNAzyme in sequence specific knockdown of
on Dicer, RHA, PACT, TRBP and Ago2 knockdown (DNAzyme)/
Figure 7 (See legend on next page.)
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Figure 7 MicroRNA profile in HIV-1 infection suggests differential role of Dicer dependent and independent RNAi. (A) shows the distinct
structure pattern in the terminal loop of hairpin precursor of microRNA known to be up-regulated (Blue Box) and down-regulated (Red Box) in
HIV-1 infection. Up-regulated miRNAs show Ago2 dependency while down-regulated show Dicer dependency. Sequences in red represents
mature miRNA in hairpin precursor. (B) the left half shows Ago2 processed molecular features in TAR miRNA (short tight loop in green box),
internal bulges (in red), and predicted cleavage sites by RNA endonucleases. These predictions were based on the functional parameters of Ago2
dependent processing reported in literature [35,36,39,40]. The right half shows the TAR2 miRNA sequence with mature stem length of 17 to 18
(in bold) as predicted to be dominantly processed by Ago2. Total RNA was prepared form the HIV-1 infected cells and subjected to Real Time
PCR to analyze the expression level of Tar1 and Tar2 miRNA. (C) shows the amplification plot for Tar1 and Tar2. Latently infected T cells (J1.1)
were treated with TNF-α (10 ng/ml) and enoxacin (50 μM) for 48 hours. Total RNA was prepared and was subjected to Real Time PCR to analyze
the expression level of Tar1 and Tar2 miRNA. (D) shows the quantification plot for Tar1 and Tar2. (E) shows the amplification for Tar2. (F) shows
the amplification plot for miR16 (an unrelated miRNA) in enoxacin treated and untreated samples. RNU6B was used as endogenous control.
Ponia et al. Retrovirology 2013, 10:97 Page 15 of 17
http://www.retrovirology.com/content/10/1/97293 T (Human Embryonic Kidney 293 T) cells were
maintained in DMEM (HiMedia) supplemented with 10%
fetal calf serum, 100 U/mL penicillin and 100 μg/mL
streptomycin (Invitrogen, California) at 37°C with 5%
CO2. Jurkat E6.1 (Human T cell lymphoblast like cell line)
and J1.1 (Latently infected T cells) cells were maintained
in RPMI 1640 media (Himedia) supplemented with glu-
tamine, 10% FCS, 100 U/mL penicillin and 100 ug/mL
streptomycin (Invitrogen) at 37°C with 5% CO2. Plasmid
transfections were performed using Lipofectamine 2000
(Invitrogen) or Jetprime (HiMedia) as per the manufac-
turer’s protocol.
Dicer dependent RNAi suppression assay
A transient gene silencing system was used for assaying
Dicer dependent RNAi response. This involves transient
transfection of plasmids coding for GFP, its correspond-
ing Dicer dependent shRNA and suppressor of RNAi in
HEK 293 T cells (as described in [14]). 30 μM Adox
(Adenosine, periodate) treatment was given to one set
of cells. Suppression of GFP expression shows a healthy
Dicer dependent RNAi process whereas its reverse shows
a compromised RNAi response. Expression of GFP is
analysed using fluorescence microscopy and quantified
through flow cytometry.
Immunoblotting
Relative levels of different proteins were compared by
immunoblot analysis. Cells were lysed with RIPA lysis
buffer (20 mM Tris [pH7.5], 150 mM NaCl, 1 mM
Na2EDTA, 1 mM EGTA, 1% Triton X-100, 1% sodium
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM
beta-glycerophosphate, 1 mM Na3VO4). Protein estima-
tion was done using BCA Protein Estimation Kit (Pierce
Biotechnology Inc.). Proteins were resolved using SDS
PAGE and transferred to Nitrocellulose Membrane
(MDI). The membranes were blocked in 5% non fat dry
milk in TBS. The membranes were washed with TBS
containing 0.1% Tween 20 (TBST) and incubated in the
same buffer overnight at 4°C in the presence of primary
antibody (1:2000 dilution). The primary antibodiesused were anti-Myc (Clontech), anti-His (Santa Cruz
Biotechnology Inc), anti-HA (Sigma Aldrich), anti-
GAPDH (Cell Signaling), anti-p24 (NIH) and anti-GST
(Amersham Pharmacia) antibodies. The membranes
were washed TBST and then incubated with secondary
antibody either anti-mouse or anti-rabbit conjugated
with horse radish peroxidase (1:10000 dilution, Jackson
Immuno Research) in 5% non fat dry milk in TBST
at room temperature. The proteins of interest were
detected with EZ western horse radish peroxidase
substrate (Biological Industries). GAPDH was used as
loading control.
Co-immunoprecipitation
Co-immunoprecipitation of over expressed proteins was
performed using HEK 293 T cells. 6 well plates were
seeded and transfected with 2 μg each of respective plas-
mids. 30 μM Adox (Adenosine, periodate) treatment was
given to one set of cells. Cells were then harvested after
48 hours and were lysed in Lysis Buffer (20 mM Tris-HCl
(pH 7.4), 40 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA,
1% Triton X-100, 1% sodium deoxycholate, 10 mM so-
dium pyrophosphate, 10 mM beta-glycerophosphate,
1 mM Na3VO4, 10 mM Sodium Fluoride). The samples
were sonicated on ice, centrifuged at maximum, and to
the soluble fraction 30 μl of 50% Ni-NTA Beads or Gluta-
thione Beads were added. The samples were incubated
at 4°C for 2 hours while rotating and subsequently the
beads were washed twice with lysis buffer and boiled
in SDS-loading buffer. The proteins were separated on
SDS-PAGE and immunoblotted with indicated antibodies
(as described previously).
Cycloheximide chase assay
HEK 293 T cells were transfected with plasmids encod-
ing Myc Tat, Myc Rev, Myc Δ Tat and Myc Δ Rev (2 μg
each). After 36 hours cycloheximide (Sigma Aldrich) was
added to a final concentration of 100 μg/mL and cells
were harvested after indicated time intervals. Lysate was
prepared and immunoblot analysis was done as described
in previously.
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HEK 293 T cells were co-transfected with pGL3 basic vec-
tor, Dicer-dependent-shLuc, pEBG, TmGST (Tat ARM
cloned in pEBG), RmGST (Rev ARM cloned in pEBG).
48 hours after transfection, cell lysate was prepared using
Passive Lysis Buffer (Promega) and luciferase activity was
measured using a luminometer. The experiments were
performed in triplicates and repeated thrice.Infection with HIV-1 and RNA isolation
pNL4.3 VSV-G pseudotyped virus was produced by
transfecting pNL4.3 and VSV-G in HEK 293 T cells by
Jet Prime Reagent (Hi Media). Virus supernatant was col-
lected after 48 hours. Multiplicity of infection (MOI) was
assessed by β-galactosidase staining of HIV-1 indicator
Tzmbl cells. Jurkat T cells were infected with pNL4-3 for
4 hours at 37°C. The infected cells were harvested
48 hours after infection and subjected to immunoblot-
ting and RNA isolation. RNA isolation was done by
Trizol reagent (Sigma-Aldrich) as per manufacturer’s
protocol.Real time PCR
Real time quantification of miRNA expression was per-
formed using TaqMan probes specific for hiv1-miR-
TAR-5p (Tar 1) and hiv1-miR-TAR-3p (Tar 2) employing
the TaqMan microRNA assay kit (Applied Biosystems)
according to manufacturer’s protocol. RNU6B (U6 RNA)
was used as endogenous control.Additional files
Additional file 1: Figure S1. DV2 NS4B Cytoplasmic Loop contains
ARM like basic motif critical for RSS activity. A. shows the similarity of
ARM from HIV-1 and basic motif of Dengue virus (DV) NS4B protein
which makes this viral module critical to RNAi modulation. Basic LM
deletion mutant in cytoplasmic loop between TMD3 and TMD4 (130-
KATREAQKR -138) shows a compromised RSS function when compared
with 2kNS4B and wt NS4B (B and C). Upper right panel shows FACS
quantification of GFP reporter while lower half is a bar plot of three
independent replicates of the above result. Dot plot depicts the number
of cells (counts) on Y-axis versus the expression of GFP reporter (FL1) on
X-axis. 2kNS4B and its variant NS4B are known RNAi suppressor as
reported in literature (Kakumani et al., 2013).
Additional file 2: Table S1. 10-23 DNAzyme sequences for RNAi
component’s Knock down.Competing interests
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